Rubric Capital Holds 7.0% Stake in Collegium Pharma
Ticker: COLL · Form: SC 13G/A · Filed: Feb 12, 2024 · CIK: 1267565
| Field | Detail |
|---|---|
| Company | Collegium Pharmaceutical, Inc (COLL) |
| Form Type | SC 13G/A |
| Filed Date | Feb 12, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**Rubric Capital still owns 7.0% of COLLEGIUM PHARMACEUTICAL, INC as of year-end 2023.**
AI Summary
Rubric Capital Management LP, a Delaware-based investment firm, filed an amended SC 13G/A on February 12, 2024, disclosing its ownership in Collegium Pharmaceutical, Inc. As of December 31, 2023, Rubric Capital beneficially owned 2,758,253 shares of Collegium Pharmaceutical's Common Stock, representing 7.0% of the company's outstanding shares. This filing indicates a significant passive investment by Rubric Capital, signaling their continued interest in the pharmaceutical company.
Why It Matters
This filing shows a major institutional investor, Rubric Capital, maintains a substantial stake in Collegium Pharmaceutical, which can influence stock stability and investor confidence.
Risk Assessment
Risk Level: low — This filing is an amendment to a passive investment, indicating no immediate change in control or strategy, thus posing low risk.
Analyst Insight
Investors should note that a major institutional investor, Rubric Capital, continues to hold a substantial 7.0% stake in Collegium Pharmaceutical, indicating continued confidence in the company's long-term prospects, but this is a passive investment and does not suggest immediate strategic changes.
Key Numbers
- 2,758,253 shares — Shares Beneficially Owned (This is the total number of Collegium Pharmaceutical shares Rubric Capital Management LP has shared voting power over as of December 31, 2023.)
- 7.0% — Percentage of Class (This represents Rubric Capital Management LP's ownership percentage of Collegium Pharmaceutical's Common Stock, indicating a significant stake.)
- December 31, 2023 — Date of Event (This is the specific date for which the ownership information is being reported in the filing.)
- $0.001 — Par Value per Share (This is the stated par value of Collegium Pharmaceutical's Common Stock.)
Key Players & Entities
- Rubric Capital Management LP (company) — the reporting person and investment firm
- Collegium Pharmaceutical, Inc. (company) — the subject company whose shares are being reported
- David Rosen (person) — a group member associated with the filing
- 03 Life Sciences (company) — an organization name listed in the subject company data
Forward-Looking Statements
- Rubric Capital Management LP will maintain its significant passive stake in Collegium Pharmaceutical, Inc. throughout 2024. (Rubric Capital Management LP) — medium confidence, target: December 31, 2024
FAQ
What is the primary purpose of this SC 13G/A filing by Rubric Capital Management LP?
The primary purpose of this SC 13G/A filing is to amend previous disclosures regarding Rubric Capital Management LP's beneficial ownership of Collegium Pharmaceutical, Inc. common stock, specifically updating the ownership as of December 31, 2023, to 2,758,253 shares, representing 7.0% of the class.
What rule under the Securities Exchange Act of 1934 is Rubric Capital Management LP filing under?
Rubric Capital Management LP is filing this Schedule 13G/A under Rule 13d-1(b) of the Securities Exchange Act of 1934, as indicated by the checked box on page 1 of the filing.
What is the CUSIP number for Collegium Pharmaceutical, Inc.'s Common Stock?
The CUSIP number for Collegium Pharmaceutical, Inc.'s Common Stock is 19459J104, as stated on page 1 and 2 of the filing.
What is the state of incorporation for Rubric Capital Management LP?
Rubric Capital Management LP is incorporated in the State of Delaware, as specified in Item 4 of the filing's cover page.
How many shares of Collegium Pharmaceutical, Inc. does Rubric Capital Management LP have sole voting power over, according to this filing?
According to Item 5 of the filing's cover page, Rubric Capital Management LP has sole voting power over 0 shares of Collegium Pharmaceutical, Inc. Common Stock, while having shared voting power over 2,758,253 shares.
Filing Stats: 1,268 words · 5 min read · ~4 pages · Grade level 10.7 · Accepted 2024-02-12 06:06:37
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of
Filing Documents
- tm245464d5_sc13ga.htm (SC 13G/A) — 66KB
- 0001104659-24-013550.txt ( ) — 68KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. DATED: February 12, 2024 RUBRIC CAPITAL MANAGEMENT LP By: /s/ Michael Nachmani Name: Michael Nachmani Title: Chief Operating Officer /s/ David Rosen DAVID ROSEN